Irene Wapnir
Academic Appointments
- Professor - Med Center Line, Surgery - General Surgery
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Stanford Women�s Cancer Center 900 Blake Wilbur Stanford, CA 94305 Tel Work (650) 721-5705 Fax (650) 736-1663
- Academic Offices
Personal Information EmailAlternate Contact Ivette Arenas, BS Administrative Associate Email Tel Work (650)721-5705Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Breast Cancer
- Cancer> Breast Cancer> Breast Cancer Clinical Trials
- Breast Cancer
- Breast Cancer - Surgery
- Breast Surgery
- General Surgery
Administrative Appointments
- Chief of Breast Surgery, Section of Surgical Oncology (2005 - present)
Honors and Awards
- Visiting Scholar, Ben Gurion University of the Negev, Israel (2012)
- Publications Committee, American Society of Breast Surgeons (2010-present)
- Protocol Chair Breast Cancer Local Recurrence Trial, NSABP (2006)
- Working Group Breast Committee, NSABP (2000)
- Awards Committee, Assoc Women Surgeons (2004)
Professional Education
| Fellowship: | Robert Wood Johnson University Hospital NJ (1988) |
| Board Certification: | General Surgery, American Board of Surgery (1986) |
| Residency: | New York Medical College NY (1985) |
| Internship: | Lincoln Med & Mental Hlth Ctr NY (1981) |
| Medical Education: | Universidad Autonoma Metropolitana, Mexico (1980) |
| MD: | Universidad A. Metropolitana, Medicine (1980) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Clinical treatment trials in Breast Cancer, especially locally recurrent breast cancer. She is chair of multicenter national trial investigating the optimal systemic treatment for women who develop a local or regional recurrence of breast cancer after mastectomy or lumpectomy. Additionally, Dr. Wapnir has initiated studies to improve surgical outcomes in several areas : decreasing ischemic complications in nipple-sparing mastectomies through perfusion imaging and protecting arm lymphatics during breast cancer surgery. Her basic and preclinical research centers on exploring the activity of breast sodium-iodide transporter (NIS) in breast cancer. Translational research protocols elucidating the potential application of NIS-based therapies are ongoing.
Clinical Trials
- Not Recruiting A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
- Recruiting Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample
- Recruiting Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
- Recruiting Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
- Recruiting Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Publications
- Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983-2009. Ann Surg Oncol. 2013; (5): 1545-50
- Poor compliance with breast cancer treatment guidelines in men undergoing breast-conserving surgery. Breast Cancer Res Treat. 2013; (1): 177-82
- MRI enhancement correlates with high grade desmoid tumor of breast. Breast J. 2012 Jul-Aug; (4): 374-6
- Integration and safety of fertility preservation in a breast cancer program. Gynecol Oncol. 2012; (3): 474-6
- The diagnostic value of nipple discharge cytology: breast imaging complements predictive value of nipple discharge cytology. J Surg Oncol. 2012; (4): 381-5
- Eusorbents and eusorption: a review of physiological events to therapeutic concepts. J Am Coll Nutr. 2011; (1): 1-10
Help
Trial Administration